Exchange: NSE·Updated 04:00 PM GMT+5:30
News
all
press releases
US tariffs on metals and pharma: Which Indian stocks are safe and which aren't: Sudip Bandyopadhyay
Indian equity markets face policy risks from US tariffs and West Asia conflict. These issues impact metals and pharmaceutical sectors. Expert Sudip Bandyopadhyay provides stock-specific insights. Vedanta and NALCO are well-positioned in aluminium. Tata Steel faces uncertainty due to European operations. Sun Pharma and Glenmark are at risk in the pharmaceutical sector due to branded drug exposure.
cityfalcon.com
More News
Indian Bank, Cummins, Glenmark Pharma: 3 stocks ideas for near-term gains, check targets
… suggested three stocks including Glenmark Pharmaceuticals Ltd, Cummins India and Indian … , supporting further upside potential. Glenmark Pharmaceuticals | Buy | Target Price: Rs 2 … Loss: Rs 1,988 Glenmark Pharma is displaying a constructive bullish setup …
cityfalcon.com
Glenmark Pharmaceuticals Launches GLIPIQ® (Semaglutide) In India
… (Glenmark), a research-led, global pharmaceutical company, today announced the launch of … been approved by the Central Drugs Standard Control Organization (CDSCO) … Business Head, India Formulations, Glenmark Pharmaceuticals Ltd., said, "Affordability …
cityfalcon.com
Glenmark Debuts Budget Semaglutide In India, Undercutting Ozempic By Over 80%
As the patents for semaglutide near expiry in several countries this month, India has introduced a cost-effective alternative.
Stocktwits
Rs 325–4,200/month: Dr Reddy’s, Sun Pharma, Glenmark kick off generic semaglutide price war
… Reddy’s Laboratories, Sun Pharma , Glenmark Pharmaceuticals , Alkem Laboratories, Zydus Lifesciences … , and Natco Pharma . Eris Lifesciences, which has a … first Indian pharma company to receive approval from the Drugs Controller General …
cityfalcon.com
Sun Pharma, Dr Reddy's, Glenmark Launch Generic Semaglutide Injection in India
… markets." Another homegrown pharma major, Glenmark Pharmaceuticals Ltd also launched its …
cityfalcon.com
Will Trump’s 100% Tariffs Derail Indian Pharma Stocks? SEBI Analyst Flags Key Levels For Traders
The new U.S. duty has already triggered a slide in major Asian pharma names, raising concerns about how Indian peers will react in the coming weeks.
Stocktwits
Trading Radar For September 25: Tata Motors, Lupin, Glenmark, Polycab, Swan Defence Stocks Are On Investors’ Watchlist
Ivalue Infosolutions set to list on the mainboard today
Stocktwits
Adani Ports, TCS, Glenmark Among SEBI Analyst’s Breakout Calls
The analyst highlights breakout opportunities in these stocks, provided that critical support levels are maintained.
Stocktwits
Glenmark Pharmaceuticals Shares Gain 3% After Launching Phase 3 Lung Cancer Drug Trial
The company has submitted a Clinical Trial Application to start the study in Russia and is preparing sites in Brazil and Mexico
Stocktwits

Advertisement|Remove ads.